Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Helminth/Parasite treatment of multiple sclerosis.
Oligoclonal band phenotypes in MS differ in their HLA class II association, while specific KIR ligands at HLA class I show association to MS in general.
Relevance of quality of life assessment for multiple sclerosis patients with memory impairment.
Olfactory Dysfunction in Multiple Sclerosis: Evidence of a Decrease in Different Aspects of Olfactory Function.
Immunohistochemical detection of sphingosine-1-phosphate receptor 1 and 5 in human multiple sclerosis lesions.
Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients.
Mimotopic peptide immunotherapy for the treatment of multiple sclerosis, an inflammatory autoimmune disease.
Epstein-Barr virus is a necessary causative agent in the pathogenesis of multiple sclerosis: Yes.
The role of percutaneous balloon compression in the treatment of trigeminal neuralgia recurring after other surgical procedures.
Job retention interventions for persons with multiple sclerosis.
Therapeutic uses of anti-α4-integrin (anti-VLA-4) antibodies in multiple sclerosis.
Statin treatment 0061ffects cytokine release and phagocytic activity in primary cultured microglia through two separable mechanisms.
Vitamin D is associated with degree of disability in patients with fully ambulatory relapsing-remitting multiple sclerosis.
Axon initial segment-associated microglia.
Skeletal muscle findings in experimental autoimmune encephalomyelitis.
Spinal segmental myoclonus as an unusual presentation of multiple sclerosis.
Trefoil factor 3 shows anti-inflammatory effects on activated microglia.
Multiple sclerosis influences on the augmentation of serum Klotho concentration.
Development and aging of superficial white matter myelin from young adulthood to old age: Mapping by vertex-based surface statistics (VBSS).
Does ability to walk reflect general functionality in inflammatory neuropathies?
Latent virus infection upregulates CD40 expression facilitating enhanced autoimmunity in a model of multiple sclerosis.
The Lin28/let-7 axis is critical for myelination in the peripheral nervous system.
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis.
Expression of immunohistochemical markers on microglia in Creutzfeldt-Jakob disease and Alzheimer's disease: morphometric study and review of the literature.
Does pain in individuals with multiple sclerosis affect employment? A systematic review and meta-analysis.
Pages
« first
‹ previous
…
629
630
631
632
633
634
635
636
637
…
next ›
last »